FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W214166965> ?p ?o ?g. }

• W214166965 endingPage "806" @default.
• W214166965 startingPage "793" @default.
• W214166965 abstract "A series of studies on the rate of inactivation of isoniazid in Indian patients with pulmonary tuberculosis in a 1-year comparison of four domiciliary chemotherapeutic regimens-three of isoniazid alone, either in moderate (HI-1 and HI-2 regimens) or in low (H regimen) dosage, and one of isoniazid in low dosage plus p-aminosalicylic acid (PAS) (PH regimen) -has recently been undertaken by the Tuberculosis Chemotherapy Centre, Madras. This paper-the third of the series-presents information on the length of time during which inhibitory concentrations of isoniazid (0.2 mug/ml or more) were maintained in the serum and on the estimated peak serum concentrations of isoniazid produced by the four regimens and relates these factors to the therapeutic effectiveness of the different regimens.THE RESULTS SUGGESTED THAT: (a) the therapeutic superiority of the PH regimen over the isoniazid-alone regimens was only in part due to the effect of PAS in enhancing the serum levels of isoniazid; (b) the therapeutic superiority of the HI-1 regimen (moderate dosage, given in one dose a day) over the HI-2 and H regimens (moderate and low dosage, respectively, given in two doses a day) was due to the higher peak serum concentration of isoniazid produced rather than to the period minimal inhibitory concentrations of isoniazid were maintained in the serum; and (c) there was a possibility that raising the peak serum concentration of isoniazid above a critical concentration of about 3 mug/ml had a greater therapeutic effect than similar proportional increases below this concentration. It also appeared that the slightly better therapeutic response observed in the slow inactivators of isoniazid than in the rapid inactivators was due to the higher peak serum concentrations of isoniazid produced; the enhanced therapeutic effect was approximately the same as would be expected from a 50% increase in isoniazid dosage." @default.
• W214166965 created "2016-06-24" @default.
• W214166965 creator A5003872258 @default.
• W214166965 creator A5054192875 @default.
• W214166965 creator A5072362660 @default.
• W214166965 creator A5087155667 @default.
• W214166965 creator A5091423358 @default.
• W214166965 date "1961-01-01" @default.
• W214166965 modified "2023-09-23" @default.
• W214166965 title "Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS." @default.
• W214166965 cites W143772677 @default.
• W214166965 cites W1524448761 @default.
• W214166965 cites W1536112177 @default.
• W214166965 cites W1591653472 @default.
• W214166965 cites W1663949815 @default.
• W214166965 cites W2003016200 @default.
• W214166965 cites W2051118087 @default.
• W214166965 cites W2060691316 @default.
• W214166965 cites W2115985043 @default.
• W214166965 cites W2315118370 @default.
• W214166965 cites W2407056494 @default.
• W214166965 cites W2407573532 @default.
• W214166965 cites W2409824929 @default.
• W214166965 cites W2413530465 @default.
• W214166965 cites W2463055704 @default.
• W214166965 cites W2253548772 @default.
• W214166965 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2555629" @default.
• W214166965 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13896635" @default.
• W214166965 hasPublicationYear "1961" @default.
• W214166965 type Work @default.
• W214166965 sameAs 214166965 @default.
• W214166965 citedByCount "24" @default.
• W214166965 crossrefType "journal-article" @default.
• W214166965 hasAuthorship W214166965A5003872258 @default.
• W214166965 hasAuthorship W214166965A5054192875 @default.
• W214166965 hasAuthorship W214166965A5072362660 @default.
• W214166965 hasAuthorship W214166965A5087155667 @default.
• W214166965 hasAuthorship W214166965A5091423358 @default.
• W214166965 hasConcept C102652120 @default.
• W214166965 hasConcept C126322002 @default.
• W214166965 hasConcept C142724271 @default.
• W214166965 hasConcept C19831878 @default.
• W214166965 hasConcept C2776967927 @default.
• W214166965 hasConcept C2780035454 @default.
• W214166965 hasConcept C2781069245 @default.
• W214166965 hasConcept C2781413609 @default.
• W214166965 hasConcept C2908628106 @default.
• W214166965 hasConcept C71924100 @default.
• W214166965 hasConcept C98274493 @default.
• W214166965 hasConceptScore W214166965C102652120 @default.
• W214166965 hasConceptScore W214166965C126322002 @default.
• W214166965 hasConceptScore W214166965C142724271 @default.
• W214166965 hasConceptScore W214166965C19831878 @default.
• W214166965 hasConceptScore W214166965C2776967927 @default.
• W214166965 hasConceptScore W214166965C2780035454 @default.
• W214166965 hasConceptScore W214166965C2781069245 @default.
• W214166965 hasConceptScore W214166965C2781413609 @default.
• W214166965 hasConceptScore W214166965C2908628106 @default.
• W214166965 hasConceptScore W214166965C71924100 @default.
• W214166965 hasConceptScore W214166965C98274493 @default.
• W214166965 hasLocation W2141669651 @default.
• W214166965 hasOpenAccess W214166965 @default.
• W214166965 hasPrimaryLocation W2141669651 @default.
• W214166965 hasRelatedWork W1698118555 @default.
• W214166965 hasRelatedWork W1964468951 @default.
• W214166965 hasRelatedWork W2016392277 @default.
• W214166965 hasRelatedWork W2064479287 @default.
• W214166965 hasRelatedWork W2071097374 @default.
• W214166965 hasRelatedWork W2411110103 @default.
• W214166965 hasRelatedWork W2886632226 @default.
• W214166965 hasRelatedWork W4226019476 @default.
• W214166965 hasRelatedWork W4233048758 @default.
• W214166965 hasRelatedWork W4214781394 @default.
• W214166965 hasVolume "25" @default.
• W214166965 isParatext "false" @default.
• W214166965 isRetracted "false" @default.
• W214166965 magId "214166965" @default.
• W214166965 workType "article" @default.